Abstract: A package includes a feminine-care article enclosed in a wrapper. The package includes product-name indicia, wherein the product-name indicia correspond to a deployment feature of the package, the feminine-care article, or the wrapper. An array of packages includes a first package and a second package. The first package includes first product-name indicia and contains a first feminine-care article enclosed in a first wrapper. The first product-name indicia correspond to a first deployment feature of the first package, the first feminine-care article, or the first wrapper. The second package includes second product-name indicia and contains a second feminine-care article enclosed in a second wrapper. The second product-name indicia correspond to a second deployment feature of the second package, the second feminine-care article, or the second wrapper.

Abstract: The present invention relates to a method of sequestering skin irritants with a skin irritant sequestering composition comprising a substrate, a hydrophilic skin irritant sequestering agent and a hydrophobic skin irritant sequestering agent. In one embodiment the sequestering agents are comprised of modified and non-modified clays. The present invention further also provides a method of sequestering skin irritants comprising administering to the stratum corneum of an individual's skin a skin irritant sequestering composition comprising a substrate, a skin irritant sequestering amount of a combination of hydrophilic and hydrophobic skin irritant sequestering agents. In one embodiment the skin irritants are bound to sequestering agents present on a substrate. In another embodiment the skin irritants are bound to sequestering agents present on the skin.

Abstract: The present invention provides a method of sequestering nasal secretion skin irritants comprising administering to the stratum corneum of an individual's skin a facial tissue comprising a tissue substrate, a nasal secretion skin irritant sequestering amount of a combination of hydrophilic and hydrophobic nasal secretion skin irritant sequestering agents. In one embodiment the sequestering agents are comprised of modified and non-modified clays. In one embodiment the skin irritants are bound to sequestering agents present on a substrate. In another embodiment the skin irritants are bound to sequestering agents present on the skin.

Abstract: Facial tissue is provided comprising a tissue substrate, a hydrophilic nasal secretion skin irritant sequestering agent and a hydrophobic nasal secretion skin irritant sequestering agent. In one embodiment the sequestering agents are comprised of modified and non-modified clays. In one embodiment the skin irritants are bound to sequestering agents present on a substrate. In another embodiment the skin irritants are bound to sequestering agents present on the skin.

Abstract: The present invention relates to a skin irritant sequestering composition comprising a tissue substrate, a hydrophilic skin irritant sequestering agent and a hydrophobic skin irritant sequestering agent. In one embodiment the sequestering agents are comprised of modified and non-modified clays. In one embodiment, the skin irritants are bound to sequestering agents present on a substrate. In another embodiment the skin irritants are bound to sequestering agents present on the skin.

Abstract: Methods of using absorbent personal care articles, such a diapers and adult incontinent briefs, comprising an absorbent article and having disposed thereon a skin irritant sequestering effective amount of an unmodified particulate skin irritant sequestering agent, and a lipophilic skin health benefit agent are provided. An unmodified particulate skin irritant sequestering agent can be a clay, such as bentonite or laponite unmodified by organic amphiphilic compounds. A lipophilic skin health benefit agent can be stearic acid, isoparrafin, petrolatum, and a combination thereof. The skin irritant can be bound to the sequestering agent either on an individual's skin or on the absorbent article.

Abstract: The present invention relates to a topical delivery system effective in depositing a thin, tenacious and substantially continuous coating of a sacrificial substrate on skin by an aqueous emulsion mediated dissolution of protein from a sheet material with subsequent transfer and deposition onto the skin. Coatings of sacrificial substrate on skin resist removal, thereby providing a protective barrier against chemically- and biochemically-induced skin damage. The treatment composition also provides a vehicle for administering an effective dose of an active agent to the skin surface.

Abstract: Absorbent personal care articles, such a diapers and adult incontinent briefs, are provided comprising an absorbent article and having disposed thereon a skin irritant sequestering effective amount of an unmodified particulate skin irritant sequestering agent, and a lipophilic skin health benefit agent. An unmodified particulate skin irritant sequestering agent can be a clay, such as bentonite or laponite unmodified by organic amphiphilic compounds. A lipophilic skin health benefit agent can be stearic acid, isoparrafin, petrolatum, and a combination thereof. The skin irritant can be bound to the sequestering agent either on an individual's skin or on the absorbent article.

Abstract: Certain antimicrobial agents, particularly chitosan- or chitin-based polymers, exhibit increased antimicrobial activity when coated onto the surface of a hydrophobic material such as polypropylene. When applied to the surface of a polypropylene nonwoven fabric, for example, the resulting material can be used for diaper liners to reduce odors and promote skin wellness.

Abstract: The present invention relates to a method for detecting the presence of P. aeruginosa in a fluid sample. The method uses PCR to amplify the expression of a segment of the exotoxin A gene sequence. The method includes treating strands of nucleotide fragments with a first oligonucleotide primer and a second oligonucleotide primer. The primers are sufficiently complementary to the fragment to hybridize a region having from about 400 to 1200 base pairs. Desirably, the first oligonucleotide primer includes the sequence 5'-ACA ACG CCC TCA GCA TCA CCA-3' and the second oligonucleotide primer includes the sequence 5'-CGG GTC GAG CAG GCA CAA C-3'.